APO Research
Talk to an analyst

APO RESEARCH · REPORT

Assistive Devices for Vulnerable Groups

Assistive technology is an umbrella term that includes assistive, adaptive, and rehabilitative devices for people with disabilities while also including the process used in selecting, locating, and using them. People who have disabilities often have difficulty performing activities of daily living (ADLs) independently, or even with assistance. ADLs are self-care activities that include toileting, mobility (ambulation), eating, bathing, dressing and grooming. Assistive technology can ameliorate the effects of disabilities that limit the ability to perform ADLs. Assistive technology promotes greater independence by enabling people to perform tasks they were formerly unable to accomplish, or had great difficulty accomplishing, by providing enhancements to, or changing methods of interacting with, the technology needed to accomplish such tasks. For example, wheelchairs provide independent mobility for those who cannot walk, while assistive eating devices can enable people who cannot feed themselves to do so. Due to assistive technology, people with disabilities have an opportunity of a more positive and easygoing lifestyle, with an increase in "social participation," "security and control," and a greater chance to "reduce institutional costs without significantly increasing household expenses."

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Assistive technology is an umbrella term that includes assistive, adaptive, and rehabilitative devices for people with disabilities while also including the process used in selecting, locating, and using them. People who have disabilities often have difficulty performing activities of daily living (ADLs) independently, or even with assistance. ADLs are self-care activities that include toileting, mobility (ambulation), eating, bathing, dressing and grooming. Assistive technology can ameliorate the effects of disabilities that limit the ability to perform ADLs. Assistive technology promotes greater independence by enabling people to perform tasks they were formerly unable to accomplish, or had great difficulty accomplishing, by providing enhancements to, or changing methods of interacting with, the technology needed to accomplish such tasks. For example, wheelchairs provide independent mobility for those who cannot walk, while assistive eating devices can enable people who cannot feed themselves to do so. Due to assistive technology, people with disabilities have an opportunity of a more positive and easygoing lifestyle, with an increase in "social participation," "security and control," and a greater chance to "reduce institutional costs without significantly increasing household expenses."

Selected research

Market Outlook & Growth Opportunities

Global Assistive Devices for Vulnerable Groups Market Outlook and Growth Opportunities 2026

21 December 2025197 pages

Choose your research edition.

Industry ResearchAssistive Devices for Vulnerable Groups Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Assistive Devices for Vulnerable Groups Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Assistive Devices for Vulnerable Groups Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Assistive Devices for Vulnerable Groups Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Assistive Devices for Vulnerable Groups Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Assistive technology is an umbrella term that includes assistive, adaptive, and rehabilitative devices for people with disabilities while also including the process used in selecting, locating, and using them. People who have disabilities often have difficulty performing activities of daily living (ADLs) independently, or even with assistance. ADLs are self-care activities that include toileting, mobility (ambulation), eating, bathing, dressing and grooming. Assistive technology can ameliorate the effects of disabilities that limit the ability to perform ADLs. Assistive technology promotes greater independence by enabling people to perform tasks they were formerly unable to accomplish, or had great difficulty accomplishing, by providing enhancements to, or changing methods of interacting with, the technology needed to accomplish such tasks. For example, wheelchairs provide independent mobility for those who cannot walk, while assistive eating devices can enable people who cannot feed themselves to do so. Due to assistive technology, people with disabilities have an opportunity of a more positive and easygoing lifestyle, with an increase in "social participation," "security and control," and a greater chance to "reduce institutional costs without significantly increasing household expenses."

Market competition is not intense. Sonova Holding, William Demant, Invacare, Ottobock, Starkey, etc. are the leaders of the industry. Sonova Holding and William Demant are the top 2 of this industry with about 28% market shares.

Mexico, China, Africa, South America, India and Southeast Asia are the middle and low income countries we focused on in our report, and these six regions account for 19% of the whole global market. China is the largest consumption place of the middle/low income countries, with a consumption market share nearly 5% globally.

Read the full market overview

This report provides an overview of the global Assistive Devices for Vulnerable Groups market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Assistive Devices for Vulnerable Groups and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Assistive Devices for Vulnerable Groups revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Assistive Devices for Vulnerable Groups market.

Assistive Devices for Vulnerable Groups Segment by Company

Sonova Holding

William Demant

Invacare

Ottobock

Starkey

GN ReSound

Sivantos

Cochlear

Widex

Sunrise Medical

Permobil Corp

MED-EL

Pride Mobility

Assistive Devices for Vulnerable Groups Segment by Type

Hearing Aids

Medical Mobility Aids & Ambulatory Devices

Vision & Reading Aids

Medical Furniture & Bathroom Safety Products

Others

Assistive Devices for Vulnerable Groups Segment by End Users

For Elderly

For Disabled

Others

Assistive Devices for Vulnerable Groups Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Assistive Devices for Vulnerable Groups status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Assistive Devices for Vulnerable Groups key companies, revenue, market share, and recent developments.

3. To split the Assistive Devices for Vulnerable Groups breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Assistive Devices for Vulnerable Groups market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Assistive Devices for Vulnerable Groups significant trends, drivers, influence factors in global and regions.

6. To analyze Assistive Devices for Vulnerable Groups competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Assistive Devices for Vulnerable Groups market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Assistive Devices for Vulnerable Groups and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Assistive Devices for Vulnerable Groups.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Assistive Devices for Vulnerable Groups industry.

Chapter 3: Detailed analysis of Assistive Devices for Vulnerable Groups company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Assistive Devices for Vulnerable Groups in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Assistive Devices for Vulnerable Groups in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Assistive Devices for Vulnerable Groups Industry Trends Table 2. Assistive Devices for Vulnerable Groups Industry Drivers Table 3. Assistive Devices for Vulnerable Groups Industry Opportunities and Challenges Table 4. Assistive Devices for Vulnerable Groups Industry Restraints Table 5. Global Assistive Devices for Vulnerable Groups Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Assistive Devices for Vulnerable Groups Revenue Share by Company (2021-2026) Table 7. Global Assistive Devices for Vulnerable Groups Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Assistive Devices for Vulnerable Groups Key Company Manufacturing Base & Headquarters Table 9. Global Assistive Devices for Vulnerable Groups Company, Product Type & Application Table 10. Global Assistive Devices for Vulnerable Groups Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Assistive Devices for Vulnerable Groups by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Hearing Aids Table 15. Significant Companies of Medical Mobility Aids & Ambulatory Devices Table 16. Significant Companies of Vision & Reading Aids Table 17. Significant Companies of Medical Furniture & Bathroom Safety Products Table 18. Significant Companies of Others Table 19. Global Assistive Devices for Vulnerable Groups Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Assistive Devices for Vulnerable Groups Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Assistive Devices for Vulnerable Groups Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Assistive Devices for Vulnerable Groups Sales Value Share by Type (2021-2026) Table 23. Global Assistive Devices for Vulnerable Groups Sales Value Share by Type (2027-2032) Table 24. Significant Companies of For Elderly Table 25. Significant Companies of For Disabled Table 26. Significant Companies of Others Table 27. Global Assistive Devices for Vulnerable Groups Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Assistive Devices for Vulnerable Groups Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Assistive Devices for Vulnerable Groups Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Assistive Devices for Vulnerable Groups Sales Value Share by Application (2021-2026) Table 31. Global Assistive Devices for Vulnerable Groups Sales Value Share by Application (2027-2032) Table 32. Global Assistive Devices for Vulnerable Groups Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Assistive Devices for Vulnerable Groups Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Assistive Devices for Vulnerable Groups Sales Value Share by Region (2021-2026) Table 35. Global Assistive Devices for Vulnerable Groups Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Assistive Devices for Vulnerable Groups Sales Value Share by Region (2027-2032) Table 37. Global Assistive Devices for Vulnerable Groups Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Assistive Devices for Vulnerable Groups Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Assistive Devices for Vulnerable Groups Sales Value Market Share by Country (2021-2026) Table 40. Global Assistive Devices for Vulnerable Groups Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Assistive Devices for Vulnerable Groups Sales Value Market Share by Country (2027-2032) Table 42. Sonova Holding Company Information Table 43. Sonova Holding Business Overview Table 44. Sonova Holding Assistive Devices for Vulnerable Groups Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Sonova Holding Assistive Devices for Vulnerable Groups Product Portfolio Table 46. Sonova Holding Recent Development Table 47. William Demant Company Information Table 48. William Demant Business Overview Table 49. William Demant Assistive Devices for Vulnerable Groups Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. William Demant Assistive Devices for Vulnerable Groups Product Portfolio Table 51. William Demant Recent Development Table 52. Invacare Company Information Table 53. Invacare Business Overview Table 54. Invacare Assistive Devices for Vulnerable Groups Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Invacare Assistive Devices for Vulnerable Groups Product Portfolio Table 56. Invacare Recent Development Table 57. Ottobock Company Information Table 58. Ottobock Business Overview Table 59. Ottobock Assistive Devices for Vulnerable Groups Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Ottobock Assistive Devices for Vulnerable Groups Product Portfolio Table 61. Ottobock Recent Development Table 62. Starkey Company Information Table 63. Starkey Business Overview Table 64. Starkey Assistive Devices for Vulnerable Groups Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Starkey Assistive Devices for Vulnerable Groups Product Portfolio Table 66. Starkey Recent Development Table 67. GN ReSound Company Information Table 68. GN ReSound Business Overview Table 69. GN ReSound Assistive Devices for Vulnerable Groups Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. GN ReSound Assistive Devices for Vulnerable Groups Product Portfolio Table 71. GN ReSound Recent Development Table 72. Sivantos Company Information Table 73. Sivantos Business Overview Table 74. Sivantos Assistive Devices for Vulnerable Groups Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sivantos Assistive Devices for Vulnerable Groups Product Portfolio Table 76. Sivantos Recent Development Table 77. Cochlear Company Information Table 78. Cochlear Business Overview Table 79. Cochlear Assistive Devices for Vulnerable Groups Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Cochlear Assistive Devices for Vulnerable Groups Product Portfolio Table 81. Cochlear Recent Development Table 82. Widex Company Information Table 83. Widex Business Overview Table 84. Widex Assistive Devices for Vulnerable Groups Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Widex Assistive Devices for Vulnerable Groups Product Portfolio Table 86. Widex Recent Development Table 87. Sunrise Medical Company Information Table 88. Sunrise Medical Business Overview Table 89. Sunrise Medical Assistive Devices for Vulnerable Groups Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sunrise Medical Assistive Devices for Vulnerable Groups Product Portfolio Table 91. Sunrise Medical Recent Development Table 92. Permobil Corp Company Information Table 93. Permobil Corp Business Overview Table 94. Permobil Corp Assistive Devices for Vulnerable Groups Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Permobil Corp Assistive Devices for Vulnerable Groups Product Portfolio Table 96. Permobil Corp Recent Development Table 97. MED-EL Company Information Table 98. MED-EL Business Overview Table 99. MED-EL Assistive Devices for Vulnerable Groups Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. MED-EL Assistive Devices for Vulnerable Groups Product Portfolio Table 101. MED-EL Recent Development Table 102. Pride Mobility Company Information Table 103. Pride Mobility Business Overview Table 104. Pride Mobility Assistive Devices for Vulnerable Groups Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Pride Mobility Assistive Devices for Vulnerable Groups Product Portfolio Table 106. Pride Mobility Recent Development Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Assistive Devices for Vulnerable Groups Product Image Figure 2. Global Assistive Devices for Vulnerable Groups Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Assistive Devices for Vulnerable Groups Market Size (2021-2032) & (US$ Million) Figure 4. Global Assistive Devices for Vulnerable Groups Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Hearing Aids Image Figure 8. Medical Mobility Aids & Ambulatory Devices Image Figure 9. Vision & Reading Aids Image Figure 10. Medical Furniture & Bathroom Safety Products Image Figure 11. Others Image Figure 12. Global Assistive Devices for Vulnerable Groups Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Assistive Devices for Vulnerable Groups Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Assistive Devices for Vulnerable Groups Sales Value Share by Type (2021-2032) Figure 15. For Elderly Image Figure 16. For Disabled Image Figure 17. Others Image Figure 18. Global Assistive Devices for Vulnerable Groups Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Assistive Devices for Vulnerable Groups Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Assistive Devices for Vulnerable Groups Sales Value Share by Application (2021-2032) Figure 21. Global Assistive Devices for Vulnerable Groups Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Assistive Devices for Vulnerable Groups Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Assistive Devices for Vulnerable Groups Sales Value (2021-2032) & (US$ Million) Figure 24. North America Assistive Devices for Vulnerable Groups Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Assistive Devices for Vulnerable Groups Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Assistive Devices for Vulnerable Groups Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Assistive Devices for Vulnerable Groups Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Assistive Devices for Vulnerable Groups Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Assistive Devices for Vulnerable Groups Sales Value (2021-2032) & (US$ Million) Figure 30. South America Assistive Devices for Vulnerable Groups Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Assistive Devices for Vulnerable Groups Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Assistive Devices for Vulnerable Groups Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Hearing Aids
  • Medical Mobility Aids & Ambulatory Devices
  • Vision & Reading Aids
  • Medical Furniture & Bathroom Safety Products
  • Others
Applications
  • For Elderly
  • For Disabled
  • Others
Companies covered
  • Sonova Holding
  • William Demant
  • Invacare
  • Ottobock
  • Starkey
  • GN ReSound
  • Sivantos
  • Cochlear
  • Widex
  • Sunrise Medical
  • Permobil Corp
  • MED-EL
  • Pride Mobility

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Assistive Devices for Vulnerable Groups Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Assistive Devices for Vulnerable Groups Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Assistive Devices for Vulnerable Groups Market Dynamics
  1. 2.1 Assistive Devices for Vulnerable Groups Industry Trends
  2. 2.2 Assistive Devices for Vulnerable Groups Industry Drivers
  3. 2.3 Assistive Devices for Vulnerable Groups Industry Opportunities and Challenges
  4. 2.4 Assistive Devices for Vulnerable Groups Industry Restraints
3 Assistive Devices for Vulnerable Groups Market by Company
  1. 3.1 Global Assistive Devices for Vulnerable Groups Company Revenue Ranking in 2025
  2. 3.2 Global Assistive Devices for Vulnerable Groups Revenue by Company (2021-2026)
  3. 3.3 Global Assistive Devices for Vulnerable Groups Company Ranking (2024-2026)
  4. 3.4 Global Assistive Devices for Vulnerable Groups Company Manufacturing Base and Headquarters
  5. 3.5 Global Assistive Devices for Vulnerable Groups Company Product Type and Application
  6. 3.6 Global Assistive Devices for Vulnerable Groups Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Assistive Devices for Vulnerable Groups Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Assistive Devices for Vulnerable Groups Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Assistive Devices for Vulnerable Groups Market by Type
  1. 4.1 Assistive Devices for Vulnerable Groups Type Introduction
  2. 4.1.1 Hearing Aids
  3. 4.1.2 Medical Mobility Aids & Ambulatory Devices
  4. 4.1.3 Vision & Reading Aids
  5. 4.1.4 Medical Furniture & Bathroom Safety Products
  6. 4.1.5 Others
  7. 4.2 Global Assistive Devices for Vulnerable Groups Sales Value by Type
  8. 4.2.1 Global Assistive Devices for Vulnerable Groups Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Assistive Devices for Vulnerable Groups Sales Value by Type (2021-2032)
  10. 4.2.3 Global Assistive Devices for Vulnerable Groups Sales Value Share by Type (2021-2032)
5 Assistive Devices for Vulnerable Groups Market by Application
  1. 5.1 Assistive Devices for Vulnerable Groups Application Introduction
  2. 5.1.1 For Elderly
  3. 5.1.2 For Disabled
  4. 5.1.3 Others
  5. 5.2 Global Assistive Devices for Vulnerable Groups Sales Value by Application
  6. 5.2.1 Global Assistive Devices for Vulnerable Groups Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Assistive Devices for Vulnerable Groups Sales Value by Application (2021-2032)
  8. 5.2.3 Global Assistive Devices for Vulnerable Groups Sales Value Share by Application (2021-2032)
6 Assistive Devices for Vulnerable Groups Regional Value Analysis
  1. 6.1 Global Assistive Devices for Vulnerable Groups Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Assistive Devices for Vulnerable Groups Sales Value by Region (2021-2032)
  3. 6.2.1 Global Assistive Devices for Vulnerable Groups Sales Value by Region: 2021-2026
  4. 6.2.2 Global Assistive Devices for Vulnerable Groups Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Assistive Devices for Vulnerable Groups Sales Value (2021-2032)
  7. 6.3.2 North America Assistive Devices for Vulnerable Groups Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Assistive Devices for Vulnerable Groups Sales Value (2021-2032)
  10. 6.4.2 Europe Assistive Devices for Vulnerable Groups Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Assistive Devices for Vulnerable Groups Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Assistive Devices for Vulnerable Groups Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Assistive Devices for Vulnerable Groups Sales Value (2021-2032)
  16. 6.6.2 South America Assistive Devices for Vulnerable Groups Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Assistive Devices for Vulnerable Groups Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Assistive Devices for Vulnerable Groups Sales Value Share by Country, 2025 VS 2032
7 Assistive Devices for Vulnerable Groups Country-level Value Analysis
  1. 7.1 Global Assistive Devices for Vulnerable Groups Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Assistive Devices for Vulnerable Groups Sales Value by Country (2021-2032)
  3. 7.2.1 Global Assistive Devices for Vulnerable Groups Sales Value by Country (2021-2026)
  4. 7.2.2 Global Assistive Devices for Vulnerable Groups Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Assistive Devices for Vulnerable Groups Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Assistive Devices for Vulnerable Groups Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Assistive Devices for Vulnerable Groups Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sonova Holding
  2. 8.1.1 Sonova Holding Company Information
  3. 8.1.2 Sonova Holding Business Overview
  4. 8.1.3 Sonova Holding Assistive Devices for Vulnerable Groups Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sonova Holding Assistive Devices for Vulnerable Groups Product Portfolio
  6. 8.1.5 Sonova Holding Recent Developments
  7. 8.2 William Demant
  8. 8.2.1 William Demant Company Information
  9. 8.2.2 William Demant Business Overview
  10. 8.2.3 William Demant Assistive Devices for Vulnerable Groups Revenue and Gross Margin (2021-2026)
  11. 8.2.4 William Demant Assistive Devices for Vulnerable Groups Product Portfolio
  12. 8.2.5 William Demant Recent Developments
  13. 8.3 Invacare
  14. 8.3.1 Invacare Company Information
  15. 8.3.2 Invacare Business Overview
  16. 8.3.3 Invacare Assistive Devices for Vulnerable Groups Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Invacare Assistive Devices for Vulnerable Groups Product Portfolio
  18. 8.3.5 Invacare Recent Developments
  19. 8.4 Ottobock
  20. 8.4.1 Ottobock Company Information
  21. 8.4.2 Ottobock Business Overview
  22. 8.4.3 Ottobock Assistive Devices for Vulnerable Groups Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ottobock Assistive Devices for Vulnerable Groups Product Portfolio
  24. 8.4.5 Ottobock Recent Developments
  25. 8.5 Starkey
  26. 8.5.1 Starkey Company Information
  27. 8.5.2 Starkey Business Overview
  28. 8.5.3 Starkey Assistive Devices for Vulnerable Groups Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Starkey Assistive Devices for Vulnerable Groups Product Portfolio
  30. 8.5.5 Starkey Recent Developments
  31. 8.6 GN ReSound
  32. 8.6.1 GN ReSound Company Information
  33. 8.6.2 GN ReSound Business Overview
  34. 8.6.3 GN ReSound Assistive Devices for Vulnerable Groups Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GN ReSound Assistive Devices for Vulnerable Groups Product Portfolio
  36. 8.6.5 GN ReSound Recent Developments
  37. 8.7 Sivantos
  38. 8.7.1 Sivantos Company Information
  39. 8.7.2 Sivantos Business Overview
  40. 8.7.3 Sivantos Assistive Devices for Vulnerable Groups Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sivantos Assistive Devices for Vulnerable Groups Product Portfolio
  42. 8.7.5 Sivantos Recent Developments
  43. 8.8 Cochlear
  44. 8.8.1 Cochlear Company Information
  45. 8.8.2 Cochlear Business Overview
  46. 8.8.3 Cochlear Assistive Devices for Vulnerable Groups Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cochlear Assistive Devices for Vulnerable Groups Product Portfolio
  48. 8.8.5 Cochlear Recent Developments
  49. 8.9 Widex
  50. 8.9.1 Widex Company Information
  51. 8.9.2 Widex Business Overview
  52. 8.9.3 Widex Assistive Devices for Vulnerable Groups Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Widex Assistive Devices for Vulnerable Groups Product Portfolio
  54. 8.9.5 Widex Recent Developments
  55. 8.10 Sunrise Medical
  56. 8.10.1 Sunrise Medical Company Information
  57. 8.10.2 Sunrise Medical Business Overview
  58. 8.10.3 Sunrise Medical Assistive Devices for Vulnerable Groups Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sunrise Medical Assistive Devices for Vulnerable Groups Product Portfolio
  60. 8.10.5 Sunrise Medical Recent Developments
  61. 8.11 Permobil Corp
  62. 8.11.1 Permobil Corp Company Information
  63. 8.11.2 Permobil Corp Business Overview
  64. 8.11.3 Permobil Corp Assistive Devices for Vulnerable Groups Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Permobil Corp Assistive Devices for Vulnerable Groups Product Portfolio
  66. 8.11.5 Permobil Corp Recent Developments
  67. 8.12 MED-EL
  68. 8.12.1 MED-EL Company Information
  69. 8.12.2 MED-EL Business Overview
  70. 8.12.3 MED-EL Assistive Devices for Vulnerable Groups Revenue and Gross Margin (2021-2026)
  71. 8.12.4 MED-EL Assistive Devices for Vulnerable Groups Product Portfolio
  72. 8.12.5 MED-EL Recent Developments
  73. 8.13 Pride Mobility
  74. 8.13.1 Pride Mobility Company Information
  75. 8.13.2 Pride Mobility Business Overview
  76. 8.13.3 Pride Mobility Assistive Devices for Vulnerable Groups Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pride Mobility Assistive Devices for Vulnerable Groups Product Portfolio
  78. 8.13.5 Pride Mobility Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst